Citation 72480

ASANO,T: MATSUOKA,K: HIDA,T: KOBAYASHI,M: KITAMURA,Y: HAYAKAWA,T: IINUMA,S: KAKINUMA,A: KATO,K:. (1994). NOVEL RETROVIRUS PROTEASE INHIBITORS, RPI-856 A,B,C AND D, PRODUCED BY STREPTOMYCES SP. AL-322.. 47(5)

Citation Details

Title	NOVEL RETROVIRUS PROTEASE INHIBITORS, RPI-856 A,B,C AND D, PRODUCED BY STREPTOMYCES SP. AL-322.
Authors	ASANO,T: MATSUOKA,K: HIDA,T: KOBAYASHI,M: KITAMURA,Y: HAYAKAWA,T: IINUMA,S: KAKINUMA,A: KATO,K:
Year	1994
Volume	47
Issue	5

Summary

Year: 1994

Journal: Unknown

Organisms and Their Experiments (1)

Streptomyces species (STREPTOMYCETACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	STREPTOMYCES ANTIBIOTIC RPI-856-A	None
2	PROTEASE(HIV) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-A	ACTIVE
3	PROTEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-A	ACTIVE
4	CATHEPSIN D INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-A	ACTIVE
5	PEPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-A	ACTIVE
6	CHYMOSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-A	EQUIVOCAL
7	TRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-A	EQUIVOCAL
8	CHYMOTRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-A	EQUIVOCAL
9	PAPAIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-A	EQUIVOCAL
10	BROMELAIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-A	EQUIVOCAL
11	THERMOLYSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-A	EQUIVOCAL
12	PROLYL ENDOPEPTIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-A	EQUIVOCAL
13	CARBOXYPEPTIDASE A INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-A	EQUIVOCAL
14	CARBOXYPEPTIDASE B INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-A	EQUIVOCAL
15	Not specified	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	STREPTOMYCES ANTIBIOTIC RPI-856-B	None
16	PROTEASE(HIV) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-B	ACTIVE
17	PROTEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-B	ACTIVE
18	CATHEPSIN D INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-B	ACTIVE
19	PEPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-B	EQUIVOCAL
20	CHYMOSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-B	EQUIVOCAL
21	TRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-B	EQUIVOCAL
22	CHYMOTRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-B	EQUIVOCAL
23	PAPAIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-B	EQUIVOCAL
24	BROMELAIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-B	EQUIVOCAL
25	THERMOLYSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-B	EQUIVOCAL
26	PROLYL ENDOPEPTIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-B	EQUIVOCAL
27	CARBOXYPEPTIDASE A INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-B	EQUIVOCAL
28	CARBOXYPEPTIDASE B INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-B	EQUIVOCAL
29	Not specified	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	STREPTOMYCES ANTIBIOTIC RPI-856-C	None
30	PROTEASE(HIV) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-C	ACTIVE
31	PROTEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-C	ACTIVE
32	CATHEPSIN D INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-C	ACTIVE
33	PEPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-C	ACTIVE
34	CHYMOSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-C	EQUIVOCAL
35	TRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-C	EQUIVOCAL
36	CHYMOTRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-C	EQUIVOCAL
37	PAPAIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-C	EQUIVOCAL
38	BROMELAIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-C	EQUIVOCAL
39	THERMOLYSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-C	EQUIVOCAL
40	PROLYL ENDOPEPTIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-C	EQUIVOCAL
41	CARBOXYPEPTIDASE A INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-C	EQUIVOCAL
42	CARBOXYPEPTIDASE B INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-C	EQUIVOCAL
43	Not specified	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	STREPTOMYCES ANTIBIOTIC RPI-856-D	None
44	PROTEASE(HIV) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-D	ACTIVE
45	PROTEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-D	ACTIVE
46	CATHEPSIN D INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-D	EQUIVOCAL
47	PEPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-D	EQUIVOCAL
48	CHYMOSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-D	EQUIVOCAL
49	TRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-D	EQUIVOCAL
50	CHYMOTRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-D	EQUIVOCAL
51	PAPAIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-D	EQUIVOCAL
52	BROMELAIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-D	EQUIVOCAL
53	THERMOLYSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-D	EQUIVOCAL
54	PROLYL ENDOPEPTIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-D	EQUIVOCAL
55	CARBOXYPEPTIDASE A INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-D	EQUIVOCAL
56	CARBOXYPEPTIDASE B INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC RPI-856-D	EQUIVOCAL

Citation 72480

Citation Details

Summary

Organisms and Their Experiments (1)

Streptomyces species (STREPTOMYCETACEAE)

Show SPARQL Queries (1)

Query 1